Dimitris Babalis
Biographic Data
| ID | 5465115 |
|---|---|
| NAME | Dimitris Babalis |
| GIVEN NAMES | Dimitris |
| FAMILY NAME | Babalis |
| SIGNATURE | BABALIS D |
| AFFILIATIONS | University Hospital of Larissa |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Transmission Dynamics of Sars-CoV-2 during an Outbreak in a Roma Community in Thessaly, Greece—Control Measures and Lessons Learned
A COVID-19 outbreak occurred among residents of a Roma settlement in Greece (8 April-4 June 2020). The aim of this study was to identify factors associated with an increased risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and to evaluate the effectiveness of control measures implemented. Data were analyzed from individuals that were tested for SARS-CoV-2 during contact tracing, population screening or hospital visit…
Rapid Test Ag 2019-nCoV (PROGNOSIS, Biotech, Larissa, Greece); Performance Evaluation in Hospital Setting with Real Time RT-PCR
The Rapid Test Ag 2019-nCoV demonstrated sufficient sensitivity, excellent specificity and could be available to be used with low overall cost. Thus, it could be used as point of care test, but also for mass screening for rapid detection of infected persons (e.g., for travelers)
No prominent works on this page.
Transmission Dynamics of Sars-CoV-2 during an Outbreak in a Roma Community in Thessaly, Greece—Control Measures and Lessons Learned
A COVID-19 outbreak occurred among residents of a Roma settlement in Greece (8 April-4 June 2020). The aim of this study was to identify factors associated with an increased risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and to evaluate the effectiveness of control measures implemented. Data were analyzed from individuals that were tested for SARS-CoV-2 during contact tracing, population screening or hospital visit…
Rapid Test Ag 2019-nCoV (PROGNOSIS, Biotech, Larissa, Greece); Performance Evaluation in Hospital Setting with Real Time RT-PCR
The Rapid Test Ag 2019-nCoV demonstrated sufficient sensitivity, excellent specificity and could be available to be used with low overall cost. Thus, it could be used as point of care test, but also for mass screening for rapid detection of infected persons (e.g., for travelers)
Biology (2 works) · Coronavirus disease 2019 (COVID-19 (2 works) · Disease (2 works) · Infectious disease (medical specialty (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 (2 works) · Virology (2 works) · 2019-20 coronavirus outbreak (1 work) · Chemistry (1 work)